BioAlliance Pharma Makes Four Presentations at the 49th ICAAC Meeting Including Three Phase III Study Results with miconazole Lauriad(R) and One with Its Integrase Inhibitor

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma has attended the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco to present results on miconazole Lauriad® and anti-integrase inhibitor.